1. Introduction {#sec1-molecules-25-00357}
===============

*Citrus aurantium* L. var. *amara* (CAVA), known as the bitter or sour orange, is a variant of *C. aurantium* L. The flowers and fruits of CAVA are recommended medicine, as well as food, by the Chinese Ministry of Health and are widely distributed in Hunan, Jiangxi, Fujian, Guangdong, and Zhejiang provinces of China \[[@B1-molecules-25-00357],[@B2-molecules-25-00357]\]. They are used for losing weight, reducing sputum, and relieving asthma in traditional Chinese medicine (TCM) \[[@B3-molecules-25-00357],[@B4-molecules-25-00357],[@B5-molecules-25-00357]\]. Recent pharmacological studies have shown that CAVA has potential antioxidant \[[@B6-molecules-25-00357]\], antitumor \[[@B7-molecules-25-00357]\], anti-inflammatory \[[@B8-molecules-25-00357]\], antimicrobial \[[@B9-molecules-25-00357]\], anti-atherosclerosis \[[@B10-molecules-25-00357]\], antianxiety \[[@B11-molecules-25-00357]\], and antiamnesic \[[@B12-molecules-25-00357]\] activities. Flavonoids and alkaloids are regarded as the primary active phytochemicals in CAVA, specifically, flavonoid glycosides, flavone, flavanone, and polymethoxyflavone \[[@B13-molecules-25-00357],[@B14-molecules-25-00357],[@B15-molecules-25-00357],[@B16-molecules-25-00357],[@B17-molecules-25-00357]\]. In addition, CAVA contains volatile oils \[[@B18-molecules-25-00357]\], limonoids \[[@B19-molecules-25-00357]\], and coumarins \[[@B19-molecules-25-00357]\]. In previous studies, only fourteen flavonoids, three coumarins, one limonin, and two alkaloids were purified and isolated from CAVA \[[@B3-molecules-25-00357],[@B6-molecules-25-00357],[@B20-molecules-25-00357],[@B21-molecules-25-00357],[@B22-molecules-25-00357]\]. In addition to these well-known constituents, a number of unknown flavonoids, alkaloids, coumarins, and limonoids were detected by HPLC-Q-TOF-MS in trace amounts and require further investigation.

Systematic phytochemical isolation, bioactivity-guided isolation, and mass spectrometry (MS) guided isolation have all been used, in previous studies, as the three primary methods to isolate and identify unknown compounds \[[@B23-molecules-25-00357]\]. MS-guided isolation is a high efficiency method for detection and isolation of new metabolites or isomers from plant samples. Compared with traditional phytochemical separation methods, this method can avoid repetitive separation of known compounds, and thus has a higher potential for the discovery of new compounds \[[@B23-molecules-25-00357],[@B24-molecules-25-00357]\]. Therefore, it is necessary to identify the chemicals using HPLC-Q-TOF-MS technologies primarily. In this study, we present a comprehensive approach to using HPLC-Q-TOF-MS, combined with a screening strategy as a rapid, sensitive, and simple method for systematic screening and identification of flavonoids, alkaloids, coumarins, and limonoids in CAVA.

In many early studies, the separation and identification of chemical constituents by liquid chromatography mass spectrometry (LC-MS) has been typically performed on a single part of a plant \[[@B3-molecules-25-00357],[@B4-molecules-25-00357],[@B21-molecules-25-00357]\], which caused a number of compounds to be omitted. In this study, samples extracted from the flowers, fruits, leaves, branches, and roots of CAVA were analyzed. Compounds that led to distinct peaks in total ion chromatography (TIC) are easily isolated and identified, but trace components and those exhibiting poor MS response that do not show significant peaks in TIC are difficult to detect and characterize. To solve this problem, a screening protocol, including non-, accurate-, and extensive-target methods was combined to find the flavonoids, alkaloids, coumarins, limonoids, and other compounds in CAVA.

The non-target method is widely used as a traditional and common means to detect compounds by screening the secondary metabolites one-by-one, based on the significant peaks of TIC. However, for some trace components or low MS response compounds, distinct peaks are not formed, and thus are easily missed \[[@B24-molecules-25-00357]\]. The accurate-target method is a means to identify compounds that have been reported in specific plants from previous studies, however, this method is only suited for well-known compounds and does not work for unknown compounds \[[@B24-molecules-25-00357]\]. The extensive-target method is a relatively comprehensive means to screen similar compounds, resulting in the formation of a series of theoretical exact masses by combining known skeletons with common substituent groups in specific plants and, then, screening the theoretical calculated mass from TIC to discover the potential molecular candidates \[[@B25-molecules-25-00357]\]. The above three methods have been used individually for screening metabolites in specific plants, however, systematic detection of compounds by combining the three methods has rarely been reported. In this study, 295 compounds were detected in CAVA by combining all three methods and 89 of them were identified.

2. Results and Discussions {#sec2-molecules-25-00357}
==========================

2.1. Establishment of the Screening Method {#sec2dot1-molecules-25-00357}
------------------------------------------

LC-MS is a fast and sensitive tool for the detection and identification of metabolites in plant medicines and foods. In previous studies, many components, especially trace compounds, have been missed due to poor screening methods. In a specific plant, analogues with the same skeleton but different substituent groups are synthesized synchronously in different amounts through specific biosynthetic pathways. Abundant compounds, or ones exhibiting a high-quality MS response, are easy to detect, while trace analogs, or compounds that exhibit a poor MS response, are always overwhelmed by complex matrices, and are difficult to discover \[[@B23-molecules-25-00357],[@B24-molecules-25-00357]\]. In light of this situation, a method for detecting analogues in CAVA using HPLC-Q-TOF-MS combined with a screening strategy was established ([Figure 1](#molecules-25-00357-f001){ref-type="fig"}). Three approaches, non-, accurate-, and extensive-target were used for systematic screening metabolites from the TICs of different CAVA samples.

A non-target method was used to screen compounds that were abundant or compounds that exhibited a high-quality MS response which can present distinct peaks in TIC and, then, fragment ions were obtained by tandem mass spectrometry (MS/MS). An accurate-target method was performed by first developing a list of all reported compounds in previous studies from the genus including their structure, molecular formula, accurate mass, and identification method. Then, the measured exact masses of candidates were obtained using extracted ion chromatogram (EIC) of the calculated precise mass of reported compounds on the TICs. Finally, the characteristic fragment ions of candidates were produced by target-MS/MS. In this study, 142 previously reported compounds were summarized; 106 components were detected in CAVA using the accurate-target method and 44 of them were identified. An extensive-target method combines known basic molecular units with different sugars to obtain a series of theoretical calculated masses and, then, EIC of the formed theoretical exact masses on the TICs of the samples were performed. If the measured MS data match the theoretical calculated mass, those combined molecules are considered to be present in the sample. Finally, the fragments of each candidates were obtained by target-MS/MS. In this study, 272 theoretical exact masses were formed by combining the eight basic units (hesperitin, naringenin, apigenin, eriodictyol, diosmetin, acacetin, luteolin, and cirsimaritin) with four common sugars (glucose, rhamnose, arabinose, and glucuronic acid). According to the TICs of flowers, fruits, leaves, roots, and branches of CAVA, the measured exact masses of 67 candidates were obtained by using an EIC method, and the target-MS/MS analysis was conducted for each candidate. Finally, the most likely structures of 38 metabolites were inferred by the fragmentation pathway of references. The above three methods have been used individually for screening of metabolites in specific plants, however, comprehensive and systematic detection of bioactive ingredients by combining the three methods has been rarely reported ([Figure 1](#molecules-25-00357-f001){ref-type="fig"}). In this study, 295 compounds were screened from CAVA by combining all three methods and 89 of them were identified.

2.2. Screening and Identification of Flavonols and Flavonol Glycosides {#sec2dot2-molecules-25-00357}
----------------------------------------------------------------------

A series of similar compounds with the same framework but different substituent groups are distributed throughout CAVA. Since these analogues typically display similar MS fragmentation behaviors, investigation of the fragmentation pathways of well-known references is a valid approach for identifying the unknown analogues. The fragmentation behaviors and characteristic diagnostic ions of ten reference samples were investigated in detail and used for identifying the flavonols and flavonol glycosides in CAVA.

In the MS/MS spectra of neoeriocitrin (**36**), poncirin (**39**), eriocitrin (**40**), naringin (**42**), naringenin (**43**), narirutin (**44**), neohesperidin (**51**), hesperidin (**56**), apigenin (**59**), and hesperitin (**61**) ([Figure S1](#app1-molecules-25-00357){ref-type="app"}), four fragmentation behaviors dominated. The first fragmentation pathway was the successive neutral loss of sugars from the protonated flavonol glycoside, and formation of the basic unit. In the MS/MS spectra of **36**, **39**, **40**, **42**, **44**, **51**, and **56**, the protonated basic unit ions at *m*/*z* 289.0678, 287.0896, 289.0672, 273.0731, 273.0731, 303.0846, and 303.0861 were formed, respectively, by the loss of a Glc-Rha group from the protonated precursor ions at *m*/*z* 597.1767, 595.2001, 597.1785, 581.1819, 581.1847, 611.1881, and 611.1983 ([Figure 2](#molecules-25-00357-f002){ref-type="fig"}). The second fragmentation pattern was the cleavage of the C-ring and formation of a series of relatively low *m*/*z* fragment ions ([Figure 2](#molecules-25-00357-f002){ref-type="fig"}). The characteristic fragment ions at *m*/*z* 153.01, 119.04, and 149.05 for **36**, **39**, **40**, **42**, **43**, **44**, **51**, **56**, **59**, and **61** were produced by a retro Diels--Alder (RDA) reaction (cleavage of j and k-bond of the C-ring). The third fragmentation pattern was the loss of small molecular groups, such as H~2~O and CO, from the basic skeleton and formation of a series of fragment ions. In the MS/MS spectra of compounds **59** and **61**, fragment ions at *m*/*z* 253.0465 and 285.0728 were generated by the loss of H~2~O moiety from the \[M + H\]^+^ ions with *m*/*z* values of 271.0572 and 303.0840, respectively \[[@B26-molecules-25-00357]\]. The final fragmentation pattern was cleavage of the sugar moiety and formation of a series of relatively low *m*/*z* fragment ions. The characteristic fragment ions at *m*/*z* 147.06 and 129.05 for **36**, **39**, **40**, **42**, **44**, **51** and **56** were formed by cleavage of the sugar moiety. These fragmentation behaviors are considered to be diagnostic pathways for flavonols and flavonol glycosides in CAVA. The proposed fragmentation patterns are shown in [Figure 2](#molecules-25-00357-f002){ref-type="fig"}.

In previous studies, the basic units of flavonols and flavonol glycosides in CAVA were apigenin (\[M + H\]^+^ *m*/*z* 271.0606), naringenin (\[M + H\]^+^ *m*/*z* 273.0763), hesperidin (\[M + H\]^+^ *m*/*z* 303.0869), eriodictyol (\[M + H\]^+^ *m*/*z* 289.0712), diosmetin (\[M + H\]^+^ *m*/*z* 301.0712), acacetin (\[M + H\]^+^ *m*/*z* 285.0763), luteolin (\[M + H\]^+^ *m*/*z* 287.0556), and cirsimaritin (\[M + H\]^+^ *m*/*z* 315.0869) \[[@B20-molecules-25-00357],[@B21-molecules-25-00357]\]. The dehydrated glucose (Glc, 162.0528), rhamnose (Rha, 146.0579), arabinose (Ara, 132.0423), and glucuronic acid (Glc A, 176.0321) were the primary substituent groups for those components. By adding no more than three sugar molecules to the skeleton, a total of 272 different theoretical exact masses were obtained. Sixty-seven candidates were produced using EIC based on the TIC of flowers, fruits, roots, leaves, and branches of CAVA and their MS/MS spectra were produced by the target-MS/MS model. The structures of 38 candidates were tentatively determined by the fragmentation pathways of flavonols and flavonol glycosides. In addition, 142 potential compounds were obtained by the non-target and accurate-target methods and 47 compounds were tentatively identified by their characteristic fragmentation behaviors. Finally, 209 flavonols and flavonol glycosides were screened by the non-, accurate-, and extensive-target methods and 58 components, including 19 flavones, 27 flavanones, and 12 polymethoxyflavonoids were identified and 45 of them were reported for the first time from this plant.

Compound **59** was screened by the three screening methods simultaneously and its MS/MS data was obtained by target-MS/MS. Compound **59** was identified as apigenin unambiguously by comparison of the retention time, MS, and MS/MS data with that of the standard ([Table 1](#molecules-25-00357-t001){ref-type="table"}). It was difficult to find compound **52** (TR = 14.22 min, [Figure 3](#molecules-25-00357-f003){ref-type="fig"}) using the non-target method because of the low content or poor response and the lack of distinct peaks in the TICs. However, this compound was easily detected by the accurate- and extensive-target methods using EIC on the TIC of different parts of CAVA. In the MS/MS spectrum of compound **52** ([Figure 4](#molecules-25-00357-f004){ref-type="fig"}), the fragment ion occurring at *m*/*z* 433.1128 was observed for the loss of a Rha residue from the protonated ion at *m*/*z* 579.1715. Subsequently, the absence of the Glc moiety was found and formed the basic skeleton at *m*/*z* 271.0599, indicating the presence of the -Glc-Rha group in the structure of compound **52**. The characteristic ions occurring at *m*/*z* 271.0599, 153.0153, and 129.0525 demonstrated that the basic skeleton for compound **52** was apigenin. Therefore, compound **52** was tentatively identified as apigenin-*O*-glucoside-*O*-rhamnoside ([Figure 4](#molecules-25-00357-f004){ref-type="fig"}). Using the same method, the remaining flavone-type compounds (**28**, **29**, **30**, **31**, **32**, **38**, **45**, **50**, **55**, **58**, **62**, **63**, **65**, **66**, **67**, **70**, and **73**) were provisionally identified ([Table 1](#molecules-25-00357-t001){ref-type="table"}) and the relevant MS/MS spectra are provided in the [Supplementary Materials (Figure S2)](#app1-molecules-25-00357){ref-type="app"}.

Compounds **36**, **39**, **40**, **42**, **43**, **44**, **51**, **56**, and **61** were unambiguously identified as neoeriocitrin, poncirin, eriocitrin, naringin, naringenin, narirutin, neohesperidin, hesperidin, and hesperitin, respectively, by comparison of the retention time, MS, and MS/MS data with the corresponding standards ([Table 1](#molecules-25-00357-t001){ref-type="table"}). The protonated ion of compound **57** was submerged in high abundance ions or complex biological matrices, making it difficult to detect by the non-target method ([Figure 3](#molecules-25-00357-f003){ref-type="fig"}). In addition, this secondary metabolite has not been reported in this genus previously. Therefore, not surprisingly, it was difficult to detect compound **57** by the accurate-target mean, however, the compound was detected with the extensive-target method by screening the theoretical exact mass on the TICs. The extensive-target method indicated that the basic skeleton of this compound was naringenin and the substituent group was Glc. In the MS/MS spectrum of compound **57** ([Figure 4](#molecules-25-00357-f004){ref-type="fig"}), the basic skeleton ion at *m*/*z* 273.0742 was formed by the loss of a Glc residue from the protonated ion occurring at *m*/*z* 435.1295. The fragments at *m*/*z* 153.0175 and 273.0742 indicated that the basic skeleton was naringenin. Thus, compound **57** was preliminarily identified as naringenin-*O*-glucoside ([Figure 4](#molecules-25-00357-f004){ref-type="fig"}). Using the same method, the remaining flavanone-type compounds (**33**, **34**, **35**, **37**, **41**, **46**, **47**, **48**, **49**, **53**, **60**, **64**, **68**, **69**, **74**, **75**, and **77**) were tentatively identified ([Table 1](#molecules-25-00357-t001){ref-type="table"}) and the relevant MS/MS spectra are provided in the [Supplementary Materials (Figure S2)](#app1-molecules-25-00357){ref-type="app"}.

Compounds **85** and **87** were unambiguously identified as nobiletin and tangeretin, respectively, by comparing the retention time, MS, and MS/MS data with the references ([Table 1](#molecules-25-00357-t001){ref-type="table"}). Compound **86** presented a distinct peak in the TIC of CAVA roots ([Figure 3](#molecules-25-00357-f003){ref-type="fig"}) and has previously been reported in this genus. Therefore, compound **86** was easily detected with the non-target and accurate-target methods. The fragmentation pathways of polymethoxyflavonoid-type compounds were investigated in detail using nobiletin (**85**) and tangeretin (**87**) as references before identifying their structures of compound **86** and other compounds. The MS behaviors of polymethoxyflavonoid-type compounds were different from other types of flavonoids. First, this type of compound only responded well in positive mode of ESI. Second, the main fragmentation route was the successive losses of small groups, such as H~2~O moiety and CH~3~ radical from the basic skeleton. In the MS/MS spectra of references **85** and **87** ([Figure S1](#app1-molecules-25-00357){ref-type="app"}), fragment ions observed at *m*/*z* 388.1133 and 358.1032 were generated by loss of CH~3~ radical from the protonated ions at *m*/*z* 403.1368 and 373.1264, respectively ([Figure 5](#molecules-25-00357-f005){ref-type="fig"}a). Fragments at *m*/*z* 355.0790 and 325.0689 were formed by neutral loss of H~2~O moiety from the ions at *m*/*z* 373.0895 and 343.0793, respectively. The third fragmentation pattern was cleavage of the C-ring and formation of relatively low *m*/*z* fragment ions. The characteristic fragment ions at *m*/*z* 211.0220 and 211.0223 for compounds **85** and **87** were formed by RDA reaction (cleavage the C-ring, [Figure 5](#molecules-25-00357-f005){ref-type="fig"}). In the MS/MS spectrum of compound **86**, the fragmentation behavior had a high similarity with polymethoxyflavonoid-type compounds. The difference in *m*/*z* values of compounds **86** and **87** was 30.0079 Da, which indicated that the structure of compound **86** has an OCH~3~ moiety fewer than that of compound **87**. According to a previous report \[[@B27-molecules-25-00357]\], compound **86** was preliminarily identified as 4′,5,6,7-pentamethoxyflavone by comparison with characteristic ions. Using the similar method, the remaining polymethoxyflavonoid-type compounds (**26**, **54**, **72**, **81**, **82**, **83**, **84**, **88**, and **89**) were tentatively identified ([Table 1](#molecules-25-00357-t001){ref-type="table"}) and the relevant MS/MS spectra are provided in the [Supplementary Materials (Figure S2)](#app1-molecules-25-00357){ref-type="app"}.

2.3. Screening and Identification of Coumarin {#sec2dot3-molecules-25-00357}
---------------------------------------------

In the MS/MS spectra of the three references (xanthotoxol (**71**), scopoletin (**76**), and auraptene (**80**) ([Figure S1](#app1-molecules-25-00357){ref-type="app"}), it is difficult to cleave the skeleton of coumarin, therefore, the primary characteristic fragmentation pathway was the loss of small molecular groups, such as CO, CH~3~, and OH, from the basic skeleton. In the MS/MS spectra of compounds **71** and **76**, fragment ions at *m*/*z* 175.0347, 147.0427, 103.0528, 150.0301, and 105.0332 were generated by the loss of a CO moiety from the protonated ions at *m*/*z* 203.0327, 175.0374, 131.0481, 178.0249, and 133.0276, respectively. In the MS/MS spectra of compounds **71** and **76**, fragment ions at *m*/*z* 131.0481 and 133.0276 were produced by the loss of a OH radical from the protonated ions at *m*/*z* 147.0427 and 150.0301, respectively. The proposed characteristic fragmentation pathways are shown in [Figure 5](#molecules-25-00357-f005){ref-type="fig"}b.

Compounds **71**, **76**, and **80** were clearly identified as xanthotoxol, scopoletin, and auraptene ([Table 1](#molecules-25-00357-t001){ref-type="table"}), respectively, by comparing the retention time, MS, and MS/MS data with those of the standards. Compound **78** presented a distinct peak in the TICs ([Figure 3](#molecules-25-00357-f003){ref-type="fig"}). In addition, this compound has been previously reported in this genus. Therefore, compound **80** could be detected easily by the non- and accurate-target methods. In the MS/MS spectrum of compound **78**, the fragmentation behavior was highly consistent with coumarin-type compounds. The difference in *m*/*z* values between compounds **78 and 71** was 14.0146 Da, which indicated that compound **78** has a CH~3~ moiety more than compound **71**. In the MS/MS spectrum of compound **78**, the high abundance fragment ion at *m*/*z* 202.0250 was generated by the loss of a CH~3~ radical from the protonated ion at *m*/*z* 217.0483, which indicated that a CH~3~ moiety was included in the structure of metabolite **78**. According to a previous report \[[@B28-molecules-25-00357]\], compound **78** was preliminarily identified as bergapten ([Figure 4](#molecules-25-00357-f004){ref-type="fig"}).

2.4. Screening and Identification of Alkaloids and Triterpenoid {#sec2dot4-molecules-25-00357}
---------------------------------------------------------------

In the MS/MS spectrum of synephrine (**15**) ([Figure S1](#app1-molecules-25-00357){ref-type="app"}), the primary fragmentation route was the loss of small molecular groups, such as CH~3~ and H~2~O, from the basic skeleton. The fragment observed at *m*/*z* 150.0917 was formed by the neutral loss of H~2~O from the protonated ion at *m*/*z* 168.1014. Successive loss of CH~3~ and CHNH moieties were observed, resulting in the ions at *m*/*z* 135.0670 and 107.0500. The proposed fragmentation pathways are shown in [Figure 5](#molecules-25-00357-f005){ref-type="fig"}c.

By comparing the retention time, MS, and MS/MS data with the standard substance, the structure of compound **15** was clearly determined ([Table S1](#app1-molecules-25-00357){ref-type="app"}). Compound **21** presented a distinct peak in the TICs ([Figure 3](#molecules-25-00357-f003){ref-type="fig"}) and has been reported previously in this genus. Therefore, compound **21** was detected easily by the non- and accurate-target methods. In the MS/MS spectrum of compound **21**, the difference in *m*/*z* value between compounds **21** and **15** was 15.9908 Da, which indicates that the structure of compound **21** results from the loss of an OH moiety in compound **15**. Moreover, the MS/MS fragmentation behaviors of both compounds are highly similar. The ion observed at *m*/*z* 121.0639 was generated corresponds to the loss of -NH~2~CH~3~ from the protonated ion at *m*/*z* 152.1065. The subsequent loss of an H~2~O moiety and formation of a peak at *m*/*z* 103.0528 was also observed. The MS/MS data indicates that -NHCH~3~ and -OH groups are present in the structure of compound **21**. According to the previous report \[[@B29-molecules-25-00357]\], it was preliminarily identified as *N*-acetylnorsynephrine. Using the same method, the remaining alkaloids (**2**, **7**, **10**, **11**, **14**, **16**, **17**, **18**, **19**, **20**, **24**, **25**, and **27**) were tentatively identified ([Table 1](#molecules-25-00357-t001){ref-type="table"}) and the relevant MS/MS spectra are provided in the [Supplementary Materials (Figure S2)](#app1-molecules-25-00357){ref-type="app"}.

Limonin compounds have been reported previously as the most common triterpenoids in CAVA \[[@B20-molecules-25-00357]\]. Compound **79** was screened by non-target and accurate-target methods and its structure was unambiguously identified as limonin by comparing the retention time, MS and MS/MS data with the reference ([Table 1](#molecules-25-00357-t001){ref-type="table"}).

2.5. Distribution of Metabolites in CAVA {#sec2dot5-molecules-25-00357}
----------------------------------------

The distribution of all identified compounds in roots, fruits, flowers, leaves, and branches of CAVA were determined using EIC, based on the TICs. More than 90% ingredients were detected and identified from the flowers and fruits, however, the number of identified metabolites from other parts were relatively small. This is the reason why the flowers and fruits were used as main medicinal parts in traditional Chinese medicine. Flavonoids, alkaloids, and coumarins were the main active ingredients of the flowers and fruits. Thirty-two characteristic compounds, such as limonin (**79**) and auraptene (**80**), were detected only from both parts. Flavonoids and flavonoid glycosides were the main metabolites of flowers, however, the polymethoxyflavonoid-type compounds (such as **78**, **81, 85,** and **87**) were only in fruits, which demonstrated that the flowers and fruits have different functions as herbal medicine or food additives. The polymethoxyflavonoid-type compounds were detected only from the family of *Citrus reticulata* Blanco in previous studies and have a wide range of biological activities, such as antioxidant, anti-inflammatory, antitumor, and antifungal activity \[[@B3-molecules-25-00357],[@B30-molecules-25-00357]\]. Those types of flavonoids were mainly distributed in the fruits and roots of CAVA. Nevertheless, the species and amounts of polymethoxyflavonoid-type compounds have a huge difference between the two parts. Some high content polymethoxyflavonoids (such as compounds **82**, **83, 88,** and **89**, comparing the relative peak area) were detected only from the roots of CAVA. Although compounds **84** and **86** were found in fruits and roots, the level of both compounds in roots was far more than that in fruits. Interestingly, some high content polymethoxyflavonoids (such as compounds **78, 79, 81**, and **85**) in fruits were difficult to detection in the roots ([Figure 3](#molecules-25-00357-f003){ref-type="fig"}). The results revealed that the roots of CAVA, usually discarded in the previous disposal process, were an important source of polymethoxyflavonoid-type metabolites for the food, medicine, and nutraceutical industries.

3. Conclusions {#sec3-molecules-25-00357}
==============

In this study, we have shown that the combination of HPLC-Q-TOF-MS with a systematic screening method constitutes a powerful analytical tool for the detection and identification of bioactive ingredients in all parts of CAVA. A total of 295 secondary metabolites were primarily found from the flowers, fruits, roots, leaves, and branches of CAVA with a systematic screening method, which is comprised of non-, accurate-, and extensive-target approaches. Eighty-nine compounds, including 19 flavones, 27 flavanones, 12 polymethoxyflavonoids, 4 coumarins, 15 alkaloids, 1 limonoids, and 11 other phytochemicals were identified by their exact masses, fragment ions, and characteristic fragmentation patterns. Sixty-nine of the compounds are reported for the first time from CAVA. To the best of our knowledge, this work marks the first comprehensive study of secondary metabolites from different parts of CAVA. In addition, the established screening method can also be applied to other plant-derived foods and medicines for systematic detection of the bioactive compounds from the complex biological matrices.

4. Materials and Methods {#sec4-molecules-25-00357}
========================

4.1. Materials and Chemicals {#sec4dot1-molecules-25-00357}
----------------------------

Deionized water was used for HPLC-Q-TOF-MS and HPLC-Q-TOF-MS/MS analysis and was purified using a Milli-Q system (Merck Millipore, Billerica, MA, USA). HPLC-grade acetonitrile and formic acid were purchased from Merck (Darmstadt, Germany) and ROE (Newark, New Castle, USA), respectively. Methanol (AR) was purchased from the National Institutes for Food and Drug Control (Beijing, China). The seventeen reference substances (seven flavonol glycosides, three flavonols, two polymethoxyflavonoids, three coumarins, one alkaloid, and one limonin), including synephrine (**15**), neoeriocitrin (**36**), poncirin (**39**), eriocitrin (**40**), naringin (**42**), naringenin (**43**), narirutin (**44**), neohesperidin (**51**), hesperidin (**56**), apigenin (**59**), hesperitin (**61**), xanthotoxol (**71**), scopoletin (**76**), auraptene (**80**), limonin (**79**), nobiletin (**85**), and tangeretin (**87**) were purchased from Shanghai Yuanye Bio-Technology Co., Ltd. (Shanghai, China).

4.2. Sample Collection and Preparation {#sec4dot2-molecules-25-00357}
--------------------------------------

The flowers, fruits, roots, branches, and leaves of CAVA were collected from LianYuan KangLu biotechnology company (Hunan, China, GPS coordinates are E 111° 51′ 23.95′ and N 27° 49′ 33.52′) and were authenticated by Prof Jianguo Zeng (Hunan Agricultural University, China). All plant parts of CAVA were freeze-dried and a portion of each was crushed using a disintegrator. Powdered samples (\~0.1 g) were extracted with methanol aqueous solution (10 mL, 80% *v*/*v*) using an ultrasonic bath for 45 min. Samples were filtered through a 0.22 μm nylon membrane before injection onto the HPLC-Q-TOF-MS system.

4.3. HPLC-Q-TOF-MS Conditions {#sec4dot3-molecules-25-00357}
-----------------------------

Agilent 1290 HPLC system (Agilent Technology, Santa Clara, California, USA) was used for the chromatography, consisting of a rapid resolution binary pump, auto-sampler, thermostated column compartment, vacuum degasser, and tunable UV detector. Separation was carried out on a Unitary-C18 column (150 mm × 2.1 mm, 2.8 μm, Accrom Co., Ltd., Dilian, China). The elution system was 0.1% aqueous formic acid solution (A) and acetonitrile (B), while linear gradient elution optimization was performed as follows: 0 to 10 min, 5% to 20% (B); 10 to 30 min, 20% to 50% (B); and 30 to 40 min, 50% to 90% (B). The flow rate was set at 0.3 mL/min, the column temperature was kept at 35 ℃, and the sample injection volume was 5 μL.

MS spectrometry experiment was performed using a 6530 Q-TOF/MS accurate-mass spectrometer (Agilent Technology) in positive electrospray ionization mode. Time-of-flight data were collected between *m*/*z* 100 to 1700 in centroid mode. The conditions for Q-TOF-MS optimization were as follows: Gas temperature, 345 ℃; fragmentor voltage, 150 V; sheath gas flow rate, 11 L/min; sheath gas temperature, 350 ℃; nebulizer gas pressure, 50 psi; sheath gas flow, 11 L/min; capillary voltage, 4000 V; OCT1 RF Vpp, 750 V; and skimmer voltage, 65 V. The TOF MS spectrometer was continuously calibrated, and *m*/*z* 121.050873 and 922.009798 were used as reference solution masses to obtain high-precision mass measurement results. The targeted MS/MS experiments were conducted with variable collision energy (10 to 105 eV) to optimize each compound.

We thank Yecheng Xiao (LianYuan KangLu biotechnology company, Hunan, China) for providing the samples.

**Sample Availability:** Samples of the compounds are available from the authors.
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###### 

The peak number (PN), retention time (TR), MS^1^, molecular formula, characteristic fragment ions, identification, screening method, and metabolic distribution of the screened and identified target compounds.

  PN        T~R~ (min)   MS^1^ ^b^ (ppm)   Formula              Characteristic MS/MS Ions (*m*/*z*)                          Identification                                                       Screening Method   Plant Part
  --------- ------------ ----------------- -------------------- ------------------------------------------------------------ -------------------------------------------------------------------- ------------------ -----------------------------------
  1 ^b^     0.67         163.1116 (0.8)    C~11~H~14~O          117.0720, 89.0605, 57.0691                                   Citrus H                                                             X                  Flower, root, fruit, leaf, branch
  2 ^b^     1.08         130.0862 (0.4)    C~6~H~11~NO~2~       84.0784, 70.0643                                             Pipecolic acid                                                       X, Y               Flower, root, fruit, leaf, branch
  3 ^b^     1.21         133.0600 (5.8)    C~4~H~8~N~2~O~3~     116.0335, 87.0543, 74.0230                                   Asparagine                                                           Y                  Flower, root, fruit, leaf, branch
  4 ^b^     1.23         277.1270 (4.2)    C~12~H~20~O~7~       259.0916, 211.0695, 133.0596                                 Citrus I                                                             X                  Flower, root, fruit, leaf, branch
  5 ^b^     1.24         147.0764 (0.1)    C~5~H~10~N~2~O~3~    130.0494, 101.0701, 84.0436                                  Glutamine                                                            Y                  Flower, fruit, leaf, branch
  6 ^b^     1.26         106.0500 (−1.2)   C~3~H~7~NO~3~        88.0389, 70.0286, 60.0437                                    Citrus J                                                             X                  Flower, fruit, leaf, branch
  7 ^b^     1.29         156.0397 (4.3)    C~5~H~5~N~3~O~3~     110.0712, 83.0606                                            Citrus A                                                             X                  Flower, root, fruit, leaf, branch
  8 ^b^     1.32         175.1193 (−2.0)   C~6~H~15~N~4~O~2~    158.0929, 130.0962, 116.0698, 70.0643, 60.0548               Arginine                                                             Y                  Flower, fruit, leaf
  9 ^b^     1.38         247.1933 (−6.4)   C~14~H~22~N~4~       144.0948, 58.0704                                            Citrus K                                                             X                  Flower, fruit, leaf
  10 ^b^    1.46         248.1993 (6.4)    C~16~H~25~NO         202.0961, 104.1008                                           Citrus B                                                             X                  Flower, root, fruit, leaf, branch
  11 ^b^    1.52         314.1586 (3.8)    C~15~H~23~NO~6~      152.1000, 121.0561, 91.0456                                  *N*-acetylnorsynephrine-rhamnoside                                   X                  Flower, root, fruit, leaf, branch
  12 ^b^    1.53         104.1067 (2.8)    C~5~H~13~NO          60.0807, 58.0649                                             Citrus M                                                             X                  Flower, fruit, leaf
  13 ^b^    1.58         116.0711 (−4.3)   C~5~H~10~NO~2~       86.0162, 70.0649                                             Citrus N                                                             X                  Flower, fruit, leaf
  14 ^b^    1.93         170.1214 (−9.2)   C~9~H~16~NO~2~       152.0893, 124.0686, 97.0715, 91.0471                         Dihydro-synephrine                                                   X                  Flower, fruit
  15 ^a^    2.11         168.0973 (8.4)    C~9~H~14~NO~2~       150.0874, 135.0633, 119.0453, 91.0507                        Synephrine                                                           X, Y               Flower, fruit
  16 ^b^    2.56         300.1432 (3.2)    C~14~H~22~NO~6~      282.1317, 138.0897, 121.0647                                 Citrus C                                                             X                  Flower, fruit, leaf, branch
  17 ^b^    2.60         268.1039 (0.5)    C~10~H~14~N~5~O~4~   136.0605, 119.0328                                           Adenosine                                                            X, Y               Flower, fruit, leaf, branch
  18 ^b^    2.61         284.0973 (5.8)    C~10~H~14~N~5~O~5~   267.1405, 152.0561, 135.0262                                 Hydroxyadenosine                                                     X                  Flower, fruit, leaf, branch
  19 ^b^    3.34         222.1120 (2.1)    C~12~H~15~NO~3~      205.1423, 87.0435                                            Citrus D                                                             X                  Flower, fruit
  20 ^b^    3.35         240.1032 (−5.4)   C~15~H~13~NO~2~      222.1059, 208.0996, 195.0853, 149.0818, 121.0559, 105.0280   Citrus E                                                             X                  Flower, fruit
  21        3.37         152.1065(3.2)     C~9~H~13~NO          121.1639, 103.0538, 77.0378                                  *N*-acetylnorsynephrine                                              X, Y               Flower, fruit
  22 ^b^    3.38         367.1830 (−6.8)   C~25~H~22~N~2~O      322.1387, 229.1012, 58.0654                                  Citrus L                                                             X                  Flower, fruit
  23 ^b^    3.41         163.0384 (3.5)    C~9~H~6~O~3~         89.0585, 57.0698                                             Citrus O                                                             X                  Flower, fruit
  24 ^b^    3.76         120.0808(−0.2)    C~8~H~9~N            103.0533, 91.0532, 77.0381                                   Citrus F                                                             X                  Flower, fruit
  25 ^b^    3.78         166.0856(3.9)     C~9~H~12~NO~2~       131.0488, 120.0799, 103.0535                                 Phenylalanine                                                        X, Y               Flower, fruit
  26 ^b^    7.55         463.1550 (8.2)    C~23~H~26~O~10~      313.0728, 185.0925, 153.0174                                 3′,4′,5′-trimethoxyflavone-*O*-arabinoside                           X                  Fruit
  27 ^b^    7.59         180.1013 (3.3)    C~10~H~13~NO~2~      163.1293, 107.0683, 89.0588                                  Citrus G                                                             X                  Flower, fruit
  28        9.18         595.1657 (0.1)    C~27~H~30~O~15~      449.1104, 287.0537, 147.0639                                 Luteolin-*O*-glucoside-*O*-rhamnoside                                Y, Z               Flower, fruit
  29 ^b^    10.86        627.1564(−1.3)    C~27~H~30~O~17~      465.0947, 303.0482, 145.0516                                 3′,4′,5′,5-hydroxy-flavone-*O*-glucoside-*O*-glucoside               X                  Flower, fruit
  30 ^b^    11.17        447.1252 (7.5)    C~22~H~22~O~10~      285.0702, 121.0957                                           Acacetin-*O*-glucoside                                               Z                  Flower, fruit
  31 ^b^    11.74        449.1104 (−5.7)   C~21~H~20~O~11~      287.0521, 147.0512, 129.0525                                 Luteolin-*O*-glucoside                                               X, Y, Z            Flower, fruit
  32 ^b^    11.75        611.1636 (−4.8)   C~27~H~30~O~16~      449.1117, 287.0532                                           Luteolin-*O*-glucoside-*O*-glucoside                                 Y, Z               Flower, fruit
  33 ^b^    11.79        451.1244 (−2.0)   C~21~H~22~O~11~      289.0704, 153.0186, 107.0429                                 Eriodictyol-*O*-glucoside                                            Y, Z               Leaf, branch
  34 ^a^    11.88        289.0700 (2.3)    C~15~H~12~O~6~       163.0365, 153.0167, 145.0281                                 Eriodictyol                                                          X, Y, Z            Leaf, branch
  35 ^b^    12.25        595.2077 (−8.4)   C~28~H~34~O~14~      449.1455, 303.0851, 153.0231                                 Hesperitin-*O*-rhamnoside-*O*-rhamnoside                             Z                  Flower, fruit
  36 ^a^    12.30        597.1835 (−3.5)   C~27~H~32~O~15~      451.1220, 289.0698, 153.0161, 147.0624, 129.0518             Neoeriocitrin                                                        X, Y, Z            Flower, fruit
  37 ^b^    12.31        597.1861 (−9.8)   C~27~H~32~O~15~      449.1391, 287.0606                                           4′-hydroxyl-flavanone-*O*-glucoside -*O*-rhamnoside                  X                  Flower, fruit
  38 ^b^    13.11        463.1244 (−1.9)   C~22~H~22~O~11~      377.9540, 301.0700, 121.1001                                 Luteolin-*O*-glucoside                                               X, Y, Z            Flower, fruit, leaf, branch
  39 ^ab^   13.20        595.2018 (0.5)    C~28~H~34~O~14~      449.1436, 287.0897, 129.0540                                 Poncirin                                                             X, Y               Flower, fruit, root
  40 ^a^    13.27        597.1818(1.2)     C~27~H~32~O~15~      331.07, 9289.0709, 147.0259                                  Eriocitrin                                                           Y, Z               Flower, fruit, root
  41 ^b^    13.29        419.1186 (−0.4)   C~17~H~22~O~12~      273.0757, 153.0152, 129.0556                                 Naringenin-*O*-rhamnoside                                            X, Y, Z            Flower, fruit, root
  42 ^a^    13.39        581.1818 (8.0)    C~27~H~32~O~14~      435.1291, 273.0727, 153.0179, 147.0641, 129.0526             Naringin                                                             Y, Z               Flower, fruit, root
  43 ^a^    13.49        273.0808 (3.0)    C~8~H~16~O~10~       153.0187, 147.0390, 119.0456                                 Naringenin                                                           X, Y, Z            Flower, fruit
  44 ^ab^   13.67        581.1841 (4.1)    C~27~H~32~O~14~      419.1302, 273.0723, 147.0623, 129.0532                       Narirutin                                                            X, Y, Z            Flower, fruit
  45        13.69        609.1805 (1.4)    C~28~H~32~O~13~      463.1229, 301.0701, 129.0644, 85.0277                        Diosmetin-*O*-glucoside-*O*-rhamnoside                               X, Y, Z            Flower, fruit, leaf, branch
  46 ^b^    13.76        419.1391(−11.6)   C~21~H~22~O~9~       383.1107,285.0716,129.0534                                   4′-Methoxy-flavanone-*O*-arabinose                                   X, Y               Flower, fruit
  47 ^b^    13.82        727.2451 (−0.9)   C~33~H~42~O~18~      527.1484, 419.1294, 315.0925129.0538                         4′,5′-Methoxy-flavanone-*O*-rhamnoside-*O*-arabinose-*O*-arabinose   X                  Flower, fruit
  48 ^b^    13.98        565.1954 (−6.7)   C~16~H~12~O~5~       419.1351, 285.0881, 147.0503                                 4′-Methoxy-flavanone-*O*-rhamnoside-*O*-arabinoside                  X                  Flower, fruit
  49 ^b^    14.15        449.1458 (−3.5)   C~22~H~24~O~10~      413.1228, 303.0833                                           Hesperitin-*O*-rhamnoside                                            Y, Z               Flower, fruit, Root, leaf, branch
  50 ^b^    14.17        593.1495 (1.0)    C~28~H~32~O~14~      447.1265, 285.0711                                           Acacetin-*O*-glucuronic acid-*O*-arabinoside                         Z                  Flower, fruit, Leaf, branch
  51 ^a^    14.19        611.1937 (5.4)    C~28~H~34~O~15~      449.1412, 303.0835, 129.0524                                 Neohesperidin                                                        X, Y, Z            Flower, fruit, Leaf, branch
  52 ^b^    14.22        579.1715 (−1.5)   C~27~H~30~O~14~      271.0599, 153.0153, 129.0525                                 Apigenin-*O*-glucoside-*O*-rhamnoside                                Y,Z                Flower, fruit, Root, leaf, branch
  53 ^b^    14.23        449.1441 (0.2)    C~22~H~24~O~10~      303.0855, 153.0199,129.0541                                  Hesperitin-*O*-rhamnoside                                            X, Z               Flower, fruit, Root, leaf, branch
  54 ^b^    14.44        345.0951 (5.1)    C~18~H~16~O~7~       303.0801, 195.0277, 153.0201                                 3′,4′,5′-trimethoxyflavone                                           Y                  Leaf, branch
  55 ^b^    14.57        593.1861 (6.5)    C~28~H~32~O~14~      447.1259, 315.0863, 153.0152                                 Cirsimaritin-*O*-arabinose                                           Z                  Flower, fruit, branch
  56 ^a^    14.58        611.1961 (1.5)    C~28~H~34~O~15~      449.1416, 303.0826, 129.0536                                 Hesperidin                                                           X, Y, Z            Flower, fruit, root, leaf, branch
  57 ^b^    14.61        435.1295 (−2.1)   C~21~H~22~O~10~      273.0742, 153.0175                                           Naringenin-*O*-glucoside                                             Z                  Flower, fruit, root
  58 ^b^    14.65        757.2226 (−5.3)   C~39~H~50~O~25~      611.1763, 287.0477, 129.0537                                 Luteolin-*O*-glucoside-*O*-rhamnoside-*O*-glucoside                  X, Z               Flower, fruit, branch
  59 ^ab^   14.68        271.0581 (6.7)    C~15~H~10~O~5~       243.0623, 153.0167, 119.0479                                 Apigenin                                                             X, Y, Z            Flower, fruit, branch
  60 ^b^    14.70        757.2214 (−3.7)   C~33~H~40~O~20~      449.1448, 303.0853, 129.0528                                 Hesperitin-*O*-glucuronic acid-*O*-arabinoside-*O*-rhamnoside        Z                  Flower, fruit, Root, leaf, branch
  61 ^a^    14.71        303.0850 (4.3)    C~16~H~14~O~4~       177.0538, 153.0365, 145.0269                                 Hesperitin                                                           X, Y, Z            Flower, fruit, root
  62 ^b^    14.86        739.2450 (−0.8)   C~34~H~42~O~18~      575.1642, 413.1240, 315.0863                                 Cirsimaritin-*O*-arabinoside-*O*-rhamnoside-*O*-rhamnoside           Z                  Flower, fruit, branch
  63 ^b^    15.17        653.1725 (−1.9)   C~29~H~32~O~17~      347.0759, 129.0522                                           3′,3,5-hydroxy-4′,5′-Methoxy-flavone-*O*-glucoside-*O*-rhamnoside    X                  Flower, fruit
  64 ^b^    15.23        435.1251 (8.0)    C~20~H~18~O~11~      273.0730, 153.0193, 147.0478                                 Naringenin-*O*-glucoside                                             X, Z               Flower, fruit
  65 ^b^    15.23        609.1797 (2.7)    C~28~H~32~O~15~      301.0690, 463.1244, 153.0151                                 Diosmetin-*O*-glucoside-*O*-rhamnoside                               X, Y, Z            Flower, fruit
  66 ^b^    15.96        579.1723 (−2.5)   C~22~H~22~O~10~      433.1139, 271.0590, 129.0534                                 Apigenin-*O*-glucoside-*O*-rhamnoside                                Z                  Fruit
  67        16.12        463.1213 (4.7)    C~22~H~22~O~11~      445.0233, 301.0707                                           Diosmetin-*O*-glucoside                                              X, Y, Z            Flower, fruit, Root, leaf, branch
  68        16.16        465.1389 (0.5)    C~22~H~24~O~11~      345.1045, 303.0839, 153.0100                                 Hesperitin-*O*-glucoside                                             Y, Z               Flower, fruit
  69 ^b^    16.36        667.2219 (2.0)    C~31~H~38~O~16~      521.1088, 273.0693                                           Naringenin-*O*-arabinoside-*O*-rhamnoside-*O*-arabinoside            Z                  Leaf, root branch
  70 ^b^    16.52        725.2224 (9.1)    C~33~H~40~O~18~      461.1186, 315.0884, 129.0551                                 Cirsimaritin-*O*-rhamnoside-*O*-arabinoside-*O*-arabinoside          X, Z               Flower, fruit, Root, leaf, branch
  71 ^a^    16.83        203.0337 (0.9)    C~11~H~6~O~4~        175.0382, 147.0439, 119.0479                                 Xanthotoxol                                                          X, Y               Flower, root, Fruit, leaf, branch
  72 ^b^    16.86        491.1511 (7.5)    C~24~H~26~O~11~      345.0871, 153.0143                                           3′,4′,5′-trimethoxyflavone-*O*-rhamnoside                            X                  Root, branch
  73 ^b^    17.12        755.2379 (1.8)    C~34~H~42~O~19~      597.1865, 271.0806, 127.0386                                 Apigenin-*O*-glucuronic acid-*O*-arabinoside-*O*-rhamnoside          Z                  Flower, fruit, root, leaf, branch
  74 ^b^    17.37        465.1427 (−6.5)   C~22~H~24~O~11~      303.0861, 153.0165                                           Hesperitin-*O*-glucoside                                             Y, Z               Flower, fruit, Root, leaf, branch
  75 ^b^    17.88        579.1971 (8.3)    C~28~H~34~O~10~      301.1401, 245.0759, 153.0158                                 4′-Methoxy-flavanone-*O*-rhamnoside-*O*-arabinoside                  X, Y               Flower, fruit, Root, leaf, branch
  76 ^a^    18.24        193.0476 (7.8)    C~10~H~8~O~4~        178.0247, 150.0302, 133.0275                                 Scopoletin                                                           X, Y               Flower, root, fruit, leaf, branch
  77 ^b^    18.72        755.2382 (1.4)    C~34~H~42~O~19~      609.1823, 303.0831, 153.0207                                 Hesperitin-*O*-glucosideacid-*O*-rhamnoside-*O*-rhamnoside           Z                  Flower, fruit
  78 ^b^    25.46        217.0483 (5.7)    C~12~H~9~O~4~        202.0250, 174.0299, 161.0581146.0345, 131.0486, 115.0532     Bergapten                                                            X, Y               Flower, fruit
  79 ^a^    25.83        471.2025 (−2.4)   C~26~H~31~O~8~       425.1931, 161.0614                                           Limonin                                                              X, Y               Flower, fruit
  80 ^a^    26.55        299.1620 (7.2)    C~19~H~22~O~3~       163.0375, 137.1314                                           Auraptene                                                            X, Y               Flower, fruit
  81 ^b^    29.95        343.1168 (2.3)    C~19~H~18~O~6~       302.1577, 296.8757                                           3′,4′,6,7-tetramethoxyflavone                                        Y                  Fruit
  82 ^b^    31.21        389.1226 (1.2)    C~20~H~20~O~8~       374.1078, 369.0821, 107.9603                                 Hydroxy-4′,5′,6,7,8-pentamethoxyflavone                              X                  Root
  83 ^b^    31.57        375.1050 (6.5)    C~19~H~18~O~8~       303.1685                                                     5,7-hydroxy-3′,4′,5′,6-tetramethoxyflavone                           X                  Root
  84 ^b^    32.60        373.1280 (0.4)    C~20~H~20~O~7~       358.0954, 343.0845                                           4′,5,6,7,8-pentamethoxy-flavone                                      X, Y               Flower, fruit, root
  85 ^a^    32.77        403.1389 (−0.3)   C~21~H~22~O~8~       388.1152, 373.0920, 355.070702, 327.0810,301.0723            Nobiletin                                                            X, Y               Flower, fruit, leaf, branch
  86 ^b^    35.26        343.1176 (0.0)    C~19~H~18~O~6~       328.0955, 313.0692, 285.0704                                 4′,5,6,7-tetramethoxyflavone                                         X, Y               Flower, fruit, root
  87 ^a^    35.48        373.1255 (6.7)    C~20~H~20~O~7~       358.1044, 343.0802, 328.07013250701                          Tangeretin                                                           X, Y               Flower, fruit, Leaf, branch
  88 ^b^    38.87        373.1288 (−1.6)   C~20~H~20~O          358.1046, 343.0811, 325.0664                                 4′,5′,6,7,8-pentamethoxy-flavone                                     X                  Root
  89 ^b^    39.41        389.1222 (2.3)    C~20~H~20~O~8~       371.2897, 374.1026, 359.0627, 356.0858                       5-hydroxy-3′,4′,6,7,8-pentamethoxyflavone                            X                  Root

^a^, those compounds were unambiguously identified by comparing the retention time, MS, and characteristic MS/MS ions with standards. ^b^, those compounds were reported for the first time in CAVA. X, those compounds were screened by the non-target method. Y, those compounds were screened by the accurate-target method. Z, those compounds were screened by the extensive-target method.

[^1]: These authors contribution equally to this work.
